·
1 Min Read

AMA applauds FDA for requiring naloxone information on opioid labels

The new labeling can serve as a starting point for discussion between patients and physicians about risks and benefits associated with opioids.

Press Releases
·
5 Min Read

AMA report shows evolving, deadlier overdose epidemic

AMA cites need to remove barriers to evidence-based care for patients with pain or a substance use disorder.

Press Releases
Car on empty railroad
·
3 Min Read

How to reignite the fight against the nation’s opioid epidemic

The COVID-19 crisis is far from over, yet the opioid epidemic continues to flare. The AMA details steps states should take, and calls on CDC to revise its opioid prescribing guideline.

Behavioral Health
Photo of Patrice Harris, MD, MA
·
6 Min Read

Dr. Harris made big mark as AMA president, but her work’s not over

In this Q&A, learn what AMA Immediate Past President Patrice A. Harris, MD, MA, sees in the year ahead for patients and physicians.

Leadership
·
11 Min Read

Experts discuss the pandemic’s impact on the opioid epidemic

The AMA is leading the fight against the COVID-19 pandemic. See the latest daily video update on how the COVID-19 pandemic has impacted the opioid epidemic.

series
Behavioral Health
AMA Update
Poster for naloxone
·
6 Min Read

COVID-19 may be worsening opioid crisis, but states can take action

The pandemic is exacerbating the ongoing opioid epidemic. The AMA is calling on states to take specific steps to save lives, reduce harm and get patients treatment they need.

Behavioral Health
·
3 Min Read

May 8, 2020: State Advocacy Update

Updated state-based COVID-19 resources and more in the latest State Advocacy Update.

Advocacy Update
·
3 Min Read

May 1, 2020: State Advocacy Update

New AMA web page to help states respond to COVID-19 and more in the latest State Adovcacy Update.

Advocacy Update
·
6 Min Read

April 24, 2020: State Advocacy Update

In the latest Advoaccy Update, the AMA called on governors to adopt civil immunity for physicians providing COVID-19-related care.

Advocacy Update